DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? reply

Henricks Linda M.; Lunenburg Carin A. T. C.; Cats Annemieke; Mathijssen Ron H. J.; Guchelaar Henk-Jan; Schellens Jan H. M.

首页> 外文期刊>Nature reviews neuroscience >DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? reply

【24h】

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? reply

机译：DPYD基因型引导的氟嘧啶治疗剂量单独化：谁以及如何？回复

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Nature reviews neuroscience》 |2019年第2期|共1页
作者
Henricks Linda M.; Lunenburg Carin A. T. C.; Cats Annemieke; Mathijssen Ron H. J.; Guchelaar Henk-Jan; Schellens Jan H. M.;
展开▼
作者单位

Netherlands Canc Inst Div Pharmacol Amsterdam Netherlands;

Leiden Univ Med Ctr Dept Med Oncol Leiden Netherlands;

Netherlands Canc Inst Div Med Oncol Dept Gastrointestinal Oncol Amsterdam Netherlands;

Erasmus Univ Med Ctr Erasmus MC Canc Inst Dept Med Oncol Rotterdam Netherlands;

Leiden Univ Med Ctr Dept Clin Pharm &

Toxicol Leiden Netherlands;

Netherlands Canc Inst Div Pharmacol Amsterdam Netherlands;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经生理学;
关键词

相似文献

外文文献
中文文献
专利

1. DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? reply [J] . Henricks Linda M., Lunenburg Carin A. T. C., Cats Annemieke, The lancet oncology . 2019,第2期

机译：DPYD基因型引导的氟嘧啶治疗剂量单独化：谁以及如何？回复
2. DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? [J] . Lam Ka On, Tong Chi Chung, Lee Victor Ho Fun, The lancet oncology . 2019,第2期

机译：DPYD基因型引导的氟嘧啶治疗剂量单独化：谁以及如何？
3. A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy [J] . Henricks Linda M., Lunenburg Carin A. T. C., de Man Femke M., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2019,第期

机译：基于氟嘧啶的抗癌治疗中预期DPYD基因型引导剂量的成本分析
4. A Solution for Brachytherapy Biologically Guided Dose Individualisation in the Treatment of Cervix Cancer [C] . W. Shaw, W.I.D. Rae, M. Alber World Congress on Medical Physics and Biomedical Engineering . 2013

机译：近距离治疗生物学指导剂量个体化治疗宫颈癌的解决方案
5. A comparative study of quality of life in patients with low-and intermediate-risk prostate cancer treated at a single institution: Stereotactic radiotherapy vs. high dose-rate brachytherapy monotherapy vs. high dose-rate brachytherapy boost [D] . Helou, Joelle. 2017

机译：单一机构治疗的中低危前列腺癌患者生活质量的比较研究：立体定向放疗与高剂量率近距离放射疗法单药疗法与高剂量率近距离放射疗法增强
6. Revisiting the Clinical Importance of DPYD*9A (c.85TC) Variant of Dihydropyrimidine Dehydrogenase (DPYD) Gene in Patients Treated with Fluoropyrimidine-Based Chemotherapy [O] . Girijesh Kumar Patel, William Taylor, Seema Singh, -1

机译：再次探讨二氢嘧啶脱氢酶（DPYD）基因的DPYD * 9A（c.85T C）变体在以氟嘧啶为基础的化学疗法治疗的患者中的临床重要性
7. Fluoropyrimidine chemotherapy: recommendations for DPYD genotyping and therapeutic drug monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy [O] . Seid Hamzic, Stefan Aebi, Markus Joerger, 2020

机译：氟嘧啶化疗：DPYD基因分型和治疗药物监测的药物替补组和个性化治疗的建议
8. Retroviral Transfer of Human Mutated Thymidylate Synthase Gene into Hematopoietic Stem Cells for Protection from High-Dose Fluoropyrimidine Toxicity. [R] . Takebe, N., Gallo, R. 2001

机译：将人突变的胸苷酸合酶基因逆转录病毒转移到造血干细胞中以防止大剂量氟嘧啶毒性。

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? reply

著录项

相似文献

相关主题

期刊订阅